Case Study

New Tumor Evaluation Modality To Measure Effectiveness Of Cancer Therapies

Cancer cells on dna stand background GettyImages-1325872227

Background

Veristat was brought on to write a sponsor’s protocol for a novel treatment that injects engineered exosomes into solid tumors. The application of a set of nuanced response criteria required information collected from injected lesions and non-injected lesions to determine a tumor’s response to the treatment.

Study Demographics

  • Indication: Advanced metastatic recurrent injectable solid tumors
  • What Kind of Trial: Immunotherapy with intratumoral delivery
  • Primary Services Provided:
    • Strategic consulting
    • Protocol development
    • Statistical analysis plan development
    • Project management

Download the available case study to learn more.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene